Natera Inc. Common Stock vs PPG Industries, Inc. — how do they compare? Natera Inc. Common Stock trades at $393.27 (market cap $57.03B), while PPG Industries, Inc. trades at $104.87 (market cap $23.24B). The key difference: Natera Inc. Common Stock is far larger — about 2.5× PPG Industries, Inc.'s market cap, and PPG Industries, Inc. pays a 2.83% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and PPG Industries, Inc. for 68 Days on average.
| NTRA | PPG | |
|---|---|---|
Market Cap | $57.03B | $23.24B |
Volume | 1,131,157 | 1,719,217 |
Sector | Health | Basic Materials |
52-Week High | $425.64 | $131.56 |
52-Week Low | $179.42 | $94.34 |
Typical Hold Time | 0 Days | 68 Days |
Enterprise Value | $56.18B | $29.11B |
Dividend Yield | — | 2.83% |
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
PPG Industries trades at $104.87, up 1.12% today, amid mixed technical signals and fundamental strength. The stock shows bearish technical indicators with support at $103 and resistance at $105, while fundamentals reveal solid profitability with 9.57% net margin and 19.63% ROE. Recent earnings show volatility with Q1 2026 beating expectations but Q2 2026 missing, with Q3 2026 results pending. The company maintains strong cash flow generation with $1.94B from operations in 2025 and recently announced a $0.74 dividend for H2-2026.
PPG presents a balanced risk-reward profile with analyst consensus pointing to 24% upside to the $130.50 price target. Strong fundamentals and institutional support (55% buy ratings) offset near-term technical weakness and segment-specific challenges in Automotive Refinish. Key risks include margin pressures in high-margin segments and European demand softness, while catalysts include Q3 earnings on Oct 27 and continued aerospace strength.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
Read more on PPG →